Replimune Group, Inc.
REPL
$15.50
-$0.10-0.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.19M | 21.23M | 18.95M | 26.64M | 32.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.95M | 72.87M | 71.53M | 83.91M | 90.00M |
| Operating Income | -67.95M | -72.87M | -71.53M | -83.91M | -90.00M |
| Income Before Tax | -69.77M | -73.46M | -71.24M | -83.10M | -86.69M |
| Income Tax Expenses | -- | -240.00K | -311.00K | -- | -- |
| Earnings from Continuing Operations | -69.77M | -73.22M | -70.93M | -83.10M | -86.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -69.77M | -73.22M | -70.93M | -83.10M | -86.69M |
| EBIT | -67.95M | -72.87M | -71.53M | -83.91M | -90.00M |
| EBITDA | -66.71M | -70.60M | -69.16M | -83.36M | -88.82M |
| EPS Basic | -0.72 | -0.77 | -0.77 | -0.90 | -0.95 |
| Normalized Basic EPS | -0.45 | -0.48 | -0.48 | -0.57 | -0.59 |
| EPS Diluted | -0.72 | -0.77 | -0.77 | -0.90 | -0.95 |
| Normalized Diluted EPS | -0.45 | -0.48 | -0.48 | -0.57 | -0.59 |
| Average Basic Shares Outstanding | 96.86M | 95.59M | 92.19M | 91.92M | 91.52M |
| Average Diluted Shares Outstanding | 96.86M | 95.59M | 92.19M | 91.92M | 91.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |